1. Home
  2. QTTB vs LSB Comparison

QTTB vs LSB Comparison

Compare QTTB & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • LSB
  • Stock Information
  • Founded
  • QTTB 2015
  • LSB 2002
  • Country
  • QTTB United States
  • LSB China
  • Employees
  • QTTB N/A
  • LSB N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • LSB
  • Sector
  • QTTB Health Care
  • LSB
  • Exchange
  • QTTB Nasdaq
  • LSB NYSE
  • Market Cap
  • QTTB 19.0M
  • LSB 22.3M
  • IPO Year
  • QTTB N/A
  • LSB N/A
  • Fundamental
  • Price
  • QTTB $1.92
  • LSB $1.05
  • Analyst Decision
  • QTTB Hold
  • LSB
  • Analyst Count
  • QTTB 8
  • LSB 0
  • Target Price
  • QTTB $24.00
  • LSB N/A
  • AVG Volume (30 Days)
  • QTTB 90.3K
  • LSB 12.7K
  • Earning Date
  • QTTB 05-08-2025
  • LSB 06-21-2025
  • Dividend Yield
  • QTTB N/A
  • LSB N/A
  • EPS Growth
  • QTTB N/A
  • LSB N/A
  • EPS
  • QTTB N/A
  • LSB N/A
  • Revenue
  • QTTB N/A
  • LSB $79,415,311.00
  • Revenue This Year
  • QTTB N/A
  • LSB $39.33
  • Revenue Next Year
  • QTTB N/A
  • LSB $75.61
  • P/E Ratio
  • QTTB N/A
  • LSB N/A
  • Revenue Growth
  • QTTB N/A
  • LSB N/A
  • 52 Week Low
  • QTTB $1.38
  • LSB $0.36
  • 52 Week High
  • QTTB $53.79
  • LSB $6.82
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 57.55
  • LSB 32.97
  • Support Level
  • QTTB $1.56
  • LSB $0.99
  • Resistance Level
  • QTTB $1.96
  • LSB $1.09
  • Average True Range (ATR)
  • QTTB 0.15
  • LSB 0.07
  • MACD
  • QTTB 0.03
  • LSB 0.02
  • Stochastic Oscillator
  • QTTB 87.80
  • LSB 24.96

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: